ME/CFS and Post-Viral Fatigue Syndrome have been among the most neglected diseases in modern medicine – underfunded, misunderstood, and without an objective diagnosis for decades. That is changing. A blood test with 96% accuracy is close to clinical approval. Clinical trials with promising compounds are running worldwide.
Patients are becoming an active part of the research community. Knowledge that was once reserved for specific circles is accessible to everyone today. Collect content from this site and feed it to the AI of your choice. As individual as this disease is – so should your approach to research be.
Every Sunday an automated system searches new scientific publications and evaluates them with AI for their relevance to ME/CFS and PVFS – including papers from other disciplines whose mechanisms may be transferable.Learn how it works →
Latest
Relevant research findings evaluated by Claude Opus – updated weekly.
Treatment of Long COVID Symptoms with Auricular Vagus Nerve Stimulation
Stimulation of the vagus nerve at the ear improved numerous symptoms such as fatigue, pain, and exercise intolerance in long COVID patients.
Read more ↓
In a retrospective analysis of nine Long COVID patients, auricular vagus nerve stimulation was performed over 4 weeks. Of 35 recorded symptoms, 28 improved immediately after treatment, 19 of which persisted until the 12-week follow-up examination. Pain, fatigue, post-exertional malaise (PEM), sleep, and dysautonomia showed particular benefit.
Auricular vagus nerve stimulation directly addresses autonomic dysfunction and possible neuroinflammation, both central mechanisms in ME/CFS and PVFS. Particularly noteworthy is the reported improvement of PEM, as this represents the core symptom of ME/CFS.
Autonomic Dysfunction (POTS Association)Chronic NeuroinflammationSleep DisturbancesOriginal study →Pain and Fatigue Therapy for Children and Adolescents (SHARK): Care Model and Initial Results
A new therapy program combines pain therapy with ME/CFS-specific strategies such as pacing for children and adolescents with chronic pain and fatigue.
Read more ↓
The SHARK care model combines elements of interdisciplinary multimodal pain therapy (IMPT) with ME/CFS management strategies, including education, symptom-oriented activity and energy management (pacing), as well as the identification of individually burdensome and stabilizing factors. Initial evaluations show improvements in several areas, as classical activation-oriented approaches reach their limits in patients with post-exertional malaise.
The model directly addresses the problem that conventional activating therapies are contraindicated in ME/CFS and PEM. It offers an important pediatric therapeutic approach that integrates pacing as a core strategy and demonstrates how pain and fatigue therapy can be designed in a manner compatible with ME/CFS.
Central SensitizationAutonomic DysfunctionOriginal study →Invasive exercise tests uncover hidden causes of fatigue and shortness of breath
A special exercise testing procedure (iCPET) can uncover hidden physical causes of fatigue and shortness of breath during exertion that remain invisible in routine examinations.
Read more ↓
The invasive cardiopulmonary exercise test (iCPET) combines respiratory gas analysis with pressure measurements in the heart and blood gas analyses during stepwise exercise. This allows characteristic patterns to be identified – such as impaired preload augmentation in autonomic dysfunction or disturbed peripheral oxygen extraction in mitochondrial myopathy. The method enables a mechanistic differentiation of exercise intolerance.
Exercise intolerance and post-exertional malaise are core symptoms of ME/CFS and Long COVID. iCPET can objectively demonstrate whether the causes lie in autonomic dysfunction (POTS), mitochondrial impairment, or impaired microcirculation – all well-established ME/CFS mechanisms. The method thus provides an objective biomarker-based approach.
Autonomic Dysfunction (POTS Association)Mitochondrial DysfunctionEndothelial DysfunctionReduced Tissue PerfusionOriginal study →What Memorial Entries Reveal About Living and Dying with ME/CFS
An analysis of 505 memorial entries of deceased individuals with ME/CFS reveals the extent of systemic neglect, clinical misdiagnosis, and social isolation.
Read more ↓
Researchers qualitatively and thematically analyzed 505 entries from the CFIDS Foundation Memorial List. Four thematic areas emerged: systemic failure of the healthcare and insurance system, clinical misdiagnoses and dismissal, social isolation, and individual functional and financial burden. Some deaths were attributed directly or indirectly to the disease.
The study systematically documents for the first time that ME/CFS can indeed be associated with mortality – a long-ignored fact. It also highlights the structural gaps in care, which can generate political pressure for action regarding research and healthcare provision.
Original study →Paper-based test for the detection of Long COVID through viral remnants in the blood
A new rapid paper test can detect traces of the coronavirus in the blood of long COVID patients and supports the theory of viral persistence.
Read more ↓
Researchers developed a paper-based immunoassay with mass spectrometry readout that detects the nucleocapsid protein (N-protein) of SARS-CoV-2 with a detection limit of 2.4 pM. In a pilot study with 20 plasma samples, long COVID patients showed a signal up to 100 times higher than healthy controls. The test remains stable even after 30 days of storage at room temperature and could be suitable for low-threshold home testing.
The study provides evidence for viral persistence as a possible mechanism of Long COVID, which is also relevant for PVFS/ME-CFS, as viral reactivation and persistence are discussed as central hypotheses. An accessible biomarker test could significantly advance diagnosis and research.
Viral PersistenceOriginal study →New Regulators of EBV Reactivation Discovered
Researchers have identified new cellular proteins that keep the Epstein-Barr virus (EBV) in a dormant state and prevent its reactivation.
Read more ↓
Using locus-specific proteomics, more than 30 proteins were identified that bind to the BZLF1 promoter – a key gene for EBV reactivation. In particular, the nucleosome remodeler CHD4 and the Polycomb complex PRC1 function as novel repressors. During lytic reactivation, loss of the PRC1 histone modification occurs, presumably through the deubiquitinase USP17.
EBV reactivation is considered a possible trigger and maintaining factor of ME/CFS and Long COVID. A better understanding of the epigenetic mechanisms that keep EBV in latency could open up new therapeutic approaches for preventing reactivation.
EBV / HHV-6 ReactivationViral PersistenceOriginal study →Genetic Factors in Long-Term Fatigue Following Cancer Therapy - Relationship to ME/CFS
Researchers have discovered a gene that is associated with persistent fatigue following cancer treatment - and this gene is also being discussed in the context of ME/CFS.
Read more ↓
In a genome-wide association study involving 1,381 prostate cancer patients following radiotherapy, the SNP rs142212041 in the ACTR3/CBWD2 gene region was significantly associated with physical long-term fatigue (P=3×10⁻⁸). Gene expression analyses revealed differences for ACTR3 and CBWD2. The authors explicitly discuss a biological mechanism that was previously described in ME/CFS.
The study identifies genetic markers for chronic fatigue that, according to the authors, could mechanistically overlap with ME/CFS. This could lead to new intervention targets and improve the understanding of the pathophysiology of chronic fatigue conditions.
Mitochondrial DysfunctionCentral SensitizationOriginal study →Perceptual disorder following drug use frequently associated with post-viral fatigue
A large study shows: People with persistent perception disorders after drug use (HPPD) suffer from post-viral fatigue and functional somatic syndromes at an above-average rate.
Read more ↓
In a retrospective cohort study with over 25,000 HPPD patients, 12.3% showed pre-existing post-viral fatigue, and the presence of PVF increased the HPPD risk in psychedelic users by a factor of 1.9. Following HPPD diagnosis, the risk for functional somatic syndromes increased (OR 2.0). The authors suspect shared pathophysiological mechanisms between HPPD, visual disturbances, anxiety, and somatic syndromes.
The study provides a statistical indication of shared mechanisms – possibly central nervous system sensitization – between post-viral fatigue, functional somatic syndromes, and perceptual disorders. This could deepen the understanding of sensitization processes in ME/CFS.
Central SensitizationAutonomic DysfunctionOriginal study →Leptin as a Driver of Microglial Inflammation in Fibromyalgia: Mechanisms and Therapeutic Approaches
The hormone leptin could amplify chronic pain and inflammation in fibromyalgia through the activation of immune cells in the brain (microglia).
Read more ↓
This review article describes how leptin – a hormone produced by adipose tissue with cytokine-like effects – can activate microglia via JAK2/STAT3, MAPK/ERK, and PI3K/Akt signaling pathways, thereby sustaining central sensitization and neuroinflammation. In fibromyalgia patients, leptin levels correlate with pain intensity and symptom burden independently of BMI. Selective leptin resistance is discussed as a possible mechanism for persistent pronociceptive signaling.
Fibromyalgia shares central features with ME/CFS such as fatigue, sleep disorders, cognitive dysfunction, and central sensitization. Microglial activation and neuroinflammation are also well-known mechanisms in ME/CFS, making leptin a potentially interesting target as an immunometabolic driver – particularly with regard to the connection between metabolic and neuroinflammatory dysregulation.
Chronic NeuroinflammationCentral SensitizationBrain Fog / Cognitive ImpairmentOriginal study →COVID-19 severity influences autonomic cardiac function - exercise as a countermeasure
After severe COVID-19, the autonomic nervous system is more severely impaired, and 16 weeks of aerobic training were able to improve these impairments.
Read more ↓
The study examined 116 individuals following COVID-19 courses of varying severity and found a significantly reduced heart rate variability (HRV) in moderate and severe cases, with increased sympathetic and reduced vagal modulation. After 16 weeks of aerobic training (APT), HRV improved in all groups regardless of initial disease severity - vagal modulation increased, while sympathetic modulation decreased.
Autonomic dysfunction is a core feature of ME/CFS and Long COVID. However, the study also reveals an important limitation: the participants appear to have tolerated the training, whereas ME/CFS patients typically suffer from post-exertional malaise (PEM). The results are therefore not directly transferable to ME/CFS, but do shed light on the pathophysiology of autonomic dysfunction following COVID-19.
Autonomic Dysfunction (POTS Association)Central SensitizationOriginal study →EBV reactivation disrupts mitochondrial recycling in T cells
EBV reactivation alters mitochondrial recycling (mitophagy) in T cells and prevents their normal cell death, leading to persistent immune activation.
Read more ↓
The study shows that EBV reactivation enhances mitochondrial fission and PINK1/Parkin-dependent mitophagy via the Drp1 signaling pathway. This blocks the apoptotic cell death of activated T cells, leading to chronic immune activation and tissue damage. The Drp1 inhibitor Mdivi-1 was able to reverse this effect in an animal model.
EBV reactivation is considered an important trigger for ME/CFS. This study provides a new mechanistic link between EBV, mitochondrial dysfunction, and impaired T cell homeostasis – three central building blocks of ME/CFS pathophysiology. Drp1 could be an interesting therapeutic target.
EBV / HHV-6 ReactivationMitochondrial DysfunctionT-Cell DysregulationOriginal study →How Chemotherapies Disrupt the Gut-Brain Axis and Trigger Fatigue
The study shows in a mouse model how certain chemotherapies disrupt the gut microbiome, trigger inflammation, and cause fatigue-like behavior.
Read more ↓
Four common chemotherapy agents were tested in female mice, and their effects on the gut-blood-brain axis as well as on fatigue- and anxiety-like behavior were investigated. Paclitaxel led to persistent central pro-inflammatory signaling, while cisplatin caused long-lasting microbiome dysbiosis. Both agents showed the strongest disruptions of the axis, with corresponding behavioral abnormalities.
The study mechanistically demonstrates how dysbiosis, systemic inflammation, and neuroinflammation can jointly lead to fatigue – a mechanism that is also being discussed in the context of ME/CFS and PVFS. It supports the hypothesis that the gut microbiome could be a therapeutic target for alleviating fatigue symptoms.
Gut Microbiome DysbiosisChronic NeuroinflammationElevated Cytokine Levels (IL-6, TNF-alpha)Original study →Glucose in cerebrospinal fluid is associated with disability, fatigue and depression in multiple sclerosis
In MS patients, elevated glucose levels in the cerebrospinal fluid are linked to greater physical disability, cognitive problems, and depression – possibly as a sign of mitochondrial dysfunction in the brain.
Read more ↓
In a study of 88 newly diagnosed, untreated MS patients, significant associations were found between elevated CSF glucose levels and worse scores on the EDSS, SDMT, and Beck Depression Inventory. Serum glucose and CSF lactate did not show such associations. The authors interpret elevated CSF glucose as a possible marker for mitochondrial dysfunction and impaired cerebral glucose metabolism.
Mitochondrial dysfunction and impaired energy metabolism in the CNS are central mechanisms in ME/CFS. The finding that peripheral blood values do not reflect CNS glucose metabolism could also be significant for the research of brain fog and fatigue in ME/CFS – it is possible that similar metabolic markers may be found in the cerebrospinal fluid.
Mitochondrial DysfunctionChronic NeuroinflammationBrain Fog / Cognitive ImpairmentOriginal study →Genetic defect in mitochondrial complex I caused by NDUFA5 variants
Researchers have discovered a new genetic defect that disrupts energy production in the mitochondria and can lead to exercise intolerance.
Read more ↓
The study identifies bi-allelic variants in the NDUFA5 gene as the cause of a mitochondrial complex I deficiency. Affected individuals present with multisystemic symptoms including neurological involvement and exercise intolerance. The function was confirmed biochemically and in a zebrafish model with movement deficits and abnormal brain activity.
Mitochondrial dysfunction and complex I defects are central mechanisms in ME/CFS. Even though this rare genetic disease has different causes, it provides valuable insights into the consequences of impaired ATP synthesis, including exercise intolerance - a core symptom of ME/CFS.
Mitochondrial DysfunctionImpaired ATP SynthesisOriginal study →Genetic and Lifestyle Factors in EBV Reactivation in the Thai Population
The study shows that certain TNF-alpha gene variants and lifestyle factors are associated with EBV reactivation in the oral cavity.
Read more ↓
In a study of 982 Thai saliva samples, EBV was detected in 20-52% of individuals. Several SNPs in the TNF-alpha promoter region (particularly rs1799964) were more frequent in EBV-positive individuals. Sex, smoking, alcohol and soft drink consumption, as well as age (21-30 years) were also significantly associated with EBV reactivation.
EBV reactivation is considered a possible trigger and amplifier of ME/CFS. The identified genetic TNF-alpha variants could explain why some people are more susceptible to chronic viral reactivation and the associated inflammatory responses – a central mechanism in PVFS/ME-CFS.
EBV / HHV-6 ReactivationElevated Cytokine Levels (IL-6, TNF-alpha)Original study →